Neuroendocrine Tumours: Diagnosis and Management, 2nd Edition (Original PDF from Publisher)

Published by Springer in 2024, the 2nd Edition of Neuroendocrine Tumours: Diagnosis and Management delivers a timely and comprehensive update on one of the most challenging and heterogeneous groups of malignancies. This edition reflects the latest clinical guidelines, molecular advancements, and therapeutic innovations in the diagnosis and management of NETs.

The book is tailored for a broad medical audience, including oncologists, endocrinologists, pathologists, nuclear medicine physicians, gastroenterologists, surgeons, and researchers working in oncology or endocrine disorders. It is also highly valuable for medical students and residents seeking to deepen their knowledge in tumor biology and patient-centered NET management.

Key Features and Highlights

• Thorough diagnostic framework covering biochemical testing, histopathology, functional imaging, and genetic profiling
• Up-to-date treatment strategies including somatostatin analogues, targeted therapies, PRRT (peptide receptor radionuclide therapy), and immunotherapy
• New content on NET classification, grading, and multidisciplinary care pathways
• Case-based discussions to translate clinical guidelines into real-world decision-making
• Expanded coverage of rare and atypical NETs, including pulmonary, pancreatic, and gastrointestinal forms
• Expert contributions from globally recognized specialists, ensuring accuracy and relevance across diverse healthcare settings

Chapters and Topics Covered

• Includes core chapters on diagnosis, staging, imaging (e.g., Ga-68 PET/CT), histopathological classification, surgical and medical treatment, and long-term patient monitoring
• Covers updates on WHO classification, ENETS/NETTER-1 trial data, and novel biomarkers
• Reviews challenges in managing metastatic, high-grade, or poorly differentiated NETs
• Emphasizes multidisciplinary coordination for optimal outcomes

About the Author(s)

This volume is authored and edited by a team of internationally renowned clinicians and researchers specializing in neuroendocrine tumors. Their combined expertise in oncology, nuclear medicine, surgery, and pathology brings a truly integrated and authoritative perspective to this complex field.

Format Details

• Available Formats: PDF
• File Size: Approx. 12.4 MB
• Language: English
• Device Compatibility: Fully compatible with Kindle, iPad, Android tablets, laptops, and eReaders. Accessible via Adobe Digital Editions, Apple Books, and other major reading platforms.

FAQs

Q1: What are the major updates in the second edition of this book?
A: The 2nd edition includes updated WHO and ENETS classifications, newer imaging modalities (e.g., Ga-68 PET/CT), expanded sections on PRRT and targeted therapies, and the latest evidence from clinical trials.

Q2: Is this book suitable for early-career clinicians or mainly specialists?
A: This book is suitable for both. It presents complex information in a clear, structured format, making it accessible for trainees while also providing the depth and clinical detail needed by experienced specialists.